1.Expression of Tim-3 in peripheral CD8 + T cells and its significance in patients with chronic hepatitis B
Wei YAO ; Jiejing XIN ; Jinsong REN ; Xiucheng PAN ; Xia FENG ; Yanchao ZHANG ; Ming CHEN
Chinese Journal of Clinical Infectious Diseases 2012;05(1):33-36
Objective To investigate the expression of T cell immunoglobulin-and mucin-domaincontaining molecule-3 (Tim-3) in peripheral CD8 +T cells and its significance in patients with chronic hepatitis B (CHB).Methods Fifty-eight CHB patients and 16 healthy controls were enrolled.Tim-3 expression in CDs + T cells was detected by flow cytometry,and quantities of IFNγ-producing HBV-specific cytotoxic T lymphocytes (CTLs) in HLA-A2 positive subjects were detected by enzyme-linked immunosorbent spot (ELISPOT) test before and after the blockade of Tim-3/Tim-3L pathway.Paired t test was performed to compare the quantities of CTLs before and after the blockade,and nonparametric Spearman correlation analysis was performed to explore the correlation in quantitive data.Results Tim-3 expression in CHB patients was (14.2 ± 8.98 )%,which was higher than that of healthy controls (4.80 ± 2.92)%,and the difference was of statistical significance (x2 =92.48,P < 0.05 ) Tim-3 expressions in 16 severe CHB patients and 42 mild CHB patients were ( 19.54 ± 10.95) % and (9.58 ± 7.30) %,respectively,and the difference was statistically significant (x2 =77.24,P < 0.05 ). Before the blockade of Tim-3/Tim-3L pathway,IFNγ-producing HBV-specific CTLs were 7.27 ± 3.14,and it increased to 19.62 ± 4.97 after the blockade ( t =2.95,P < 0.05 ).Conclusion The upregulation of Tim-3 on peripheral CD8 + T cells may inhibit HBV-specific CTLs,and the blockade of Tim-3 pathway can enhance the proliferation of IFNγ-producing HBV-specific CTLs,thus can enhance antiviral effect.
2.Clinical significance of expression and phosphorylation of FAK in human osteosarcoma
Ke REN ; Nan YAO ; Jun LU ; Xin SHI ; Sujia WU ; Jie MA ; Chen WANG
Chinese Journal of Clinical Oncology 2017;44(10):474-482
Objective: To examine expression patterns of focal adhesion kinase (FAK) and its activated form, phosphorylated FAK (pFAK),in human osteosarcoma and to investigate the correlation of FAK expression with clinicopathological parameters and prognosis. Functional consequence of manipulating FAK protein levels was also investigated in human osteosarcoma cell lines. Methods: Immunohistochemical staining was used to detect FAK and pFAK levels in pathologically archived materials from 113 patients with primary osteosarcoma. Kaplan-Meier survival and Cox regression analyses were used to evaluate prognoses. The role of FAK in cytological behavior of MG63 and 143B human osteosarcoma cell lines was studied via the FAK protein knockdown with siRNA. Cell proliferation, migration, invasiveness, and apoptosis were assessed using cell counting kit-8, Transwell, and Annexin V/PI staining methods. Results: Both FAK and pFAK were overexpressed in osteosarcoma patients. Tumor cells exhibited cytoplasmicity and occasional membranous immunoreactivity for FAK. A total of 42 cases (37.17%) mainly showed expressed pFAK in cytoplasm of osteosarcoma cells. No overexpression staining of anti-FAK and anti-pFAK antibodies was observed in normal cancellous bone tissues or negative controls. Significant differences were observed in overall survival between FAK-/pFAK- and FAK+/pFAK- groups (P=0.016), FAK+/pFAK- and FAK+/pFAK+ groups (P=0.012), and FAK-/pFAK- and FAK+/pFAK+ groups (P<0.001). All groups showed similar metastasis-free survival. Cox proportional hazard analysis showed that FAK expression profile is an independent indicator of both overall andmetastasis-free survival. siRNA-based knockdown of FAK significantly reducedmigration and invasion of MG63 and 143B cells and affected proliferation and apoptosis in osteosarcoma cells. Conclusion: Osteosarcoma malignancies in vitro and in vivo were correlated with overexpression and phosphorylation of FAK. These findings suggest that FAK plays an important biological role in osteosarcoma carcinogenesis. This study provides a better understanding of diagnostic and prognostic relevance of FAK overexpression and phosphorylation in osteosarcoma patients. Therefore, FAK and pFAK can be used as independent predictors of overall and metastasis-free survival in osteosarcoma patients.
3.Study on 4977 base pair deletion in mitochondrial DNA in lung cancer tissues.
Ji-gang DAI ; Ying-bin XIAO ; Jia-xin MIN ; Guo-qiang ZHANG ; Ke YAO ; Ren-jie ZHOU
Chinese Journal of Pathology 2005;34(12):804-805
Adenocarcinoma
;
genetics
;
Adult
;
Age Factors
;
Aged
;
Base Sequence
;
Carcinoma, Squamous Cell
;
genetics
;
DNA, Mitochondrial
;
genetics
;
Female
;
Humans
;
Lung Neoplasms
;
genetics
;
Male
;
Middle Aged
;
Sequence Deletion
;
Smoking
;
genetics
4.Endoscope with subsidiary incision access for orbital blowout fracture.
Xu ZHU ; Ming LI ; Jian-xin YAO ; Hongcheng HAN ; Shubei REN ; Qiuying CAI ; Jinghui XIE
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2005;40(8):626-627
Adolescent
;
Adult
;
Endoscopy
;
Ethmoid Sinus
;
surgery
;
Eyelids
;
surgery
;
Female
;
Humans
;
Male
;
Middle Aged
;
Orbital Fractures
;
surgery
;
Otorhinolaryngologic Surgical Procedures
;
methods
;
Young Adult
5.Advances in pathogenesis of pituitary adenomas.
Yao YONG ; Dai CONG-XIN ; Wang REN-ZHI
Acta Academiae Medicinae Sinicae 2011;33(2):127-131
Along with the rapid development of molecular biology, cell biology, genetics, and immunology, there is a new understanding on the pathogenesis of pituitary adenomas. The pathogenesis of pituitary adenomas is considered to be related with gene mutation, growth factors, cell receptors, transcription factors, and cellular signaling pathways.
Adenoma
;
genetics
;
metabolism
;
Humans
;
Mutation
;
Pituitary Neoplasms
;
genetics
;
metabolism
;
Signal Transduction
6.Application of third party testing in information system construction of Sichuan grass-root medical and health institutions
Minghui SHEN ; Changqi FENG ; Li FENG ; Yunpeng MAO ; Ren DENG ; Shuai WANG ; Jiefeng WU ; Xin YAO ; Zhihua YU
Chinese Journal of Medical Library and Information Science 2014;(3):15-18,22
After a description of the background and ideas to introduce the third party testing in information system construction of Sichuan grass-root medical and health institutions and the specific working contents of third party testing team, the problems to which importance should be attached in information system construction were analyzed with suggestions put forward for their solution .
7.The clinical and radiographi c characteristics of erosive hand osteoarthritis
Xiaoying ZHANG ; Xin ZHI ; Rong MU ; Limin REN ; Nan WU ; Yue YANG ; Yunshan ZHOU ; Haihong YAO ; Nan HONG ; Zhanguo LI
Chinese Journal of Rheumatology 2017;21(7):455-460,封3
Objective To evaluate the clinical and radiographic characteristics and function of erosive hand osteoarthritis (EOA) patients. Methods Data were obtained from 19 patients with EOA, including their social conditions, clinical conditions, radiographic scores and hand function evaluation. The number of hand osteoarthritis (HOA) patients was 312. The control group consisted of non-EOA patients with hand osteoarthritis with a ratio of 4:1 to EOA patients. A non-parameter test analysis was performed. All data were analyzed by SPSS 23.0 statistical analysis, t test, χ2 test, Fisher exact probility and Spearman's correlations analysis were used for statistical analysis. Results Totally data of 19 patients were collected. Eighteen were female. Onset age was (56±8). Average duration was 56 (12~120) months. FIHOA scores of all the EOA patients were at least 5. All the erosions of 39 joints were characteristically central and erosive changes in 7 joints (18%) showed up as gull-wing. Among 39 erosive joints, including 12 (31%) E and 27 (69%) R, 34 (87%) distal interphalangeal joints were involved. Data analysis found out that EOA patients had longer disease duration (Z=2.610, P=0.009), more severe K-L level (44 ±11 vs 26 ±7, t=7.134, P<0.01), higher AUSCAN total score (28±6 vs 21±7, t=3.781, P<0.01) and higher AUSCAN function score (18±6 vs 12±6, t=4.042, P<0.01). The differences of ESR and CRP were not significant between EOA and non-EOA patients. Conclusion Erosions seen in EOA patients are centrally located gull-wing in the DIP joints. EOA patients have longer duration, more severe radiographic damage and worse joint function.
8.Multi-disciplinary diagnosis and treatment of a malignant pheochromocytoma with multiple metastases
Yawen ZHENG ; Xinwei ZHANG ; Zhongli ZHAN ; Zhaoxiang YE ; Wengui XU ; Peiguo WANG ; Zhi GUO ; Xin YAO ; Guangru XIE ; Dingzhi HUANG ; Xiubao REN
Chinese Journal of Clinical Oncology 2013;(21):1332-1336
Malignant pheochromocytomas are rare tumors that arise from chromaffin tissue, and the diagnostic criterion of malig-nancy is based on the development of metastases. In the case a patient suffers the tumor with liver, lung and bone metastases. However, the test results of tumor markers, gastroscopy, chest and abdominal CT, and PET-CT examination are hard to make a definite diagnosis. The patient was finally diagnosed with malignant pheochromocytoma with liver, lung and bone metastases following the needle biopsy of liver and underwent the excision of a right adrenal pheochromocytoma. Therapeutic standard for the malignant pheochromocytomas is not available so far. It is reported that chemotherapeutic CVD regimen (cyclophosphamide, vincristine, and daecarbazine) and suni-tinib may be effectual in the alike cases. The patient received two cycles of CVD and one cycle of sunitinib, nevertheless, slow progres-sion of the disease remained after the treatment. The results of multi-disciplinary treatment have suggested that 131I-MIBG may just be a choice for this patient.
9.Advances in medical treatment of clinically nonfunctioning pituitary adenomas.
Cong-xin DAI ; Yong YAO ; Feng CAI ; Xiao-hai LIU ; Si-hai MA ; Ren-zhi WANG
Acta Academiae Medicinae Sinicae 2012;34(3):298-302
Clinically nonfunctioning pituitary adenomas are the most common types among pituitary adenomas. These tumors are usually diagnosed in their later stages due to the absence of clinical symptoms and detectable hormonal hypersecretion. Although these tumors are benign, they are hard to be completely removed during neurosurgery due to the massive invasion into the surrounding tissues at diagnosis. Furthermore, relapse is common. In recent years, medical treatment of pituitary adenomas has witnessed a rapid development. New medications have shown certain effectiveness in reducing the tumor size and improving the clinical symptoms.
Adenoma
;
drug therapy
;
Humans
;
Pituitary Neoplasms
;
drug therapy
10.Small interfering RNA targeting C-erbB-2 gene increases the radiosensitivity of lung adenocarcinoma cells in vitro.
Hua-Shan SHI ; De-Lian REN ; Xin-Mei CAO ; Li HUANG ; Yao JIANG
Journal of Southern Medical University 2008;28(11):1977-1980
OBJECTIVETo investigate the effect of small interfering RNA (siRNA) targeting C-erbb-2 oncogene on the radiosensitivity of C-erbb-2-overexpressing lung adenocarcinoma cell line.
METHODSFour pairs of siRNA targeting the coding sequence of C-erbb-2 mRNA were synthesized and their interference effects were evaluated using quantitative real-time fluorescence PCR. The siRNA with the best interference effects was transfected into Calu-3 cells, which were then exposed to 2 or 5 Gy irradiation, with the cells with transfection or irradiation alone as the control groups. The cell apoptosis after the treatment was detected using annexin V-FITC Kit.
RESULTSThe apoptosis rate of the Calu cells was 7.767-/+0.551 in the blank group, 14.400-/+1.114 in the interference group, 11.867-/+0.737 in 2 Gy irradition group, 23.000-/+1.664 in 2 Gy irradiation + interference group, 16.100-/+0.624 in 5 Gy irradiation group, and 27.900-/+1.709 in 5 Gy irradiation+interference group.
CONCLUSIONThe siRNA targeting C-erbb-2 gene can enhance the radiosensitivity of Calu-3 cells to gamma-ray and increase their apoptosis rate following gamma-ray exposure in vitro.
Adenocarcinoma ; genetics ; pathology ; Apoptosis ; drug effects ; radiation effects ; Cell Line, Tumor ; Genes, erbB-2 ; genetics ; Humans ; Lung Neoplasms ; genetics ; pathology ; RNA Interference ; RNA, Small Interfering ; genetics ; Radiation Dosage ; Radiation Tolerance ; genetics